Afatinib Recruiting Phase 2 / 3 Trials for Recurrent Non-Small Cell Lung Carcinoma / Stage IV Non-Small Cell Lung Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs